Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP

Molecular Cloning: A Laboratory Manual

Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589

BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR

Sadler, J. E. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.395 · Cited by 1,369

IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK

Sullivan, J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92463-6 · Cited by 969

Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells

Wagner, D. D. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.95.1.355 · Cited by 703

1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE

Mannucci, P. M., Pareti, F. I., Ruggeri, Z. M., & Capitanio, A. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91197-7 · Cited by 604

Molecular cloning of the receptor for human antidiuretic hormone

Birnbaumer, M., Seibold, A. M., Gilbert, S., Ishido, M., Barberis, C., Antaramián, A., Brabet, P., & Rosenthal, W. (1992) · Nature · doi:10.1038/357333a0 · Cited by 539

Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus

Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524 · cited 1×

Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years

Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515 · Cited by 436

Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years

Mannucci, P. M. (1997) · Blood · doi:10.1182/blood.v90.7.2515.2515_2515_2521 · Cited by 398

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

Mannucci, P. M., Åberg, M., Nilsson, I. M., & Robertson, B. (1975) · British Journal of Haematology · doi:10.1111/j.1365-2141.1975.tb00521.x · Cited by 391

Phosphatidylinositol‐3,4,5‐triphosphate‐dependent Rac exchange factor 1 regulates epinephrine‐induced exocytosis of Weibel–Palade bodies

van Hooren, K. W. E. M., van Breevoort, D., Fernandez‐Borja, M., Meijer, A. B., Eikenboom, J. C. J., Bierings, R., & Voorberg, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12460 · Cited by 28

Vasopressin in Vasodilatory Shock

Ukor, I.-F., & Walley, K. R. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.004 · Cited by 27

Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactionsin vitro

Calmer, S., Ferkau, A., Larmann, J., Johanning, K., Czaja, E., Hagl, C. M., Echtermeyer, F. G., Goudeva, L., Heuft, H., & Theilmeier, G. (2013) · Platelets · doi:10.3109/09537104.2013.767442 · Cited by 27

Platelet sequestration and activation during GalTKO.hCD46 pig lung perfusion by human blood is primarily mediated by GPIb, GPIIb/IIIa, and von Willebrand Factor

Burdorf, L., Riner, A. N., Rybak, E., Salles, I. I., Meyer, S. F. D., Shah, A. M., Quinn, K. J., Harris, D. G., Zhang, T., Parsell, D. M., et al. (2016) · Xenotransplantation · doi:10.1111/xen.12236 · Cited by 27

Cav3.1 (α1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells

Zhou, C., Chen, H., Lu, F., Sellak, H., Daigle, J. A., ALEXEYEV, M. F., Xi, Y., Ju, J., van MOURIK, J. A., & Wu, S. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00377.2006 · Cited by 27

Von Willebrand factor in diagnostics and treatment of cardiovascular disease: Recent advances and prospects

Kozlov, S. G., Денисович, О. С., Avtaeva, Y., Сергеевич, М. И., Matroze, E., & Ахнафович, Г. З. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1038030 · Cited by 26

The potential use of desmopressin to correct hypothermia-induced impairment of primary haemostasis—An in vitro study using PFA-100®

Ying, C. L. A., Tsang, S. F., & Ng, K. F. J. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2007.07.009 · Cited by 26

Sphingosine-1-Phosphate Receptor 3 Mediates Sphingosine-1-Phosphate Induced Release of Weibel-Palade Bodies from Endothelial Cells

van Hooren, K. W. E. M., Spijkers, L. J. A., van Breevoort, D., Fernandez‐Borja, M., Bierings, R., van Buul, J. D., Alewijnse, A. E., Peters, S. L. M., & Voorberg, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091346 · Cited by 25

Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues

Fish, R. J., Yang, H., Viglino, C., Schorer, R., Dunoyer-Geindre, S., & Kruithof, E. K. O. (2007) · Biochemical Journal · doi:10.1042/bj20070404 · Cited by 25

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey

Windyga, J., Dolan, G., Altisent, C., Κατσαρού, Ό., Fernández, M. F. L., Zülfikar, B., & EHTSB, T. (2015) · Haemophilia · doi:10.1111/hae.12763 · Cited by 24

Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes

Potier, L., Roussel, R., Marre, M., Bjornstad, P., Cherney, D. Z., Boustany, R. E., Fumeron, F., Venteclef, N., Gautier, J., Hadjadj, S., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1062 · Cited by 24

Vasopressin Antagonists: Role in the Management of Hyponatremia

Yeates, K., & Morton, A. R. (2006) · American Journal of Nephrology · doi:10.1159/000094539 · Cited by 24

Management of VWD

Neff, A. T., & Sidonio, R. F. (2014) · Hematology · doi:10.1182/asheducation-2014.1.536 · Cited by 23

The Effect of Vasopressin and Related Compounds at V1aand V2Receptors in Animal Models Relevant to Human Disease*

Petersen, M. B. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_299.x · Cited by 23

Intrafamilial phenotype variability in nephrogenic diabetes insipidus

Kalenga, K., Persu, A., Goffin, E. J., Lavenne-Pardonge, E., Cangh, P. J. V., Bichet, D. G., & Devuyst, O. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31993 · Cited by 23

In Vivo Gene Transfer Strategies to Achieve Partial Correction of von Willebrand Disease

Wang, L., Rosenberg, J. B., De, B. P., Ferris, B., Wang, R., Rivella, S., Kaminsky, S. M., & Crystal, R. G. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.238 · Cited by 22

Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

Garona, J., Sobol, N. T., Pífano, M., Segatori, V. I., Gomez, D. E., Ripoll, G. V., & Alonso, D. F. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.040 · Cited by 22

In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall

Rybałtowski, M., Suzuki, Y., Mogami, H., Iwona, C., Brzóska, T., Tanaka, A., Banno, F., Miyata, T., & Urano, T. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0958-x · Cited by 21

Lifecycle of Weibel-Palade bodies

Mourik, M. J., & Eikenboom, J. C. J. (2016) · Hämostaseologie · doi:10.5482/hamo-16-07-0021 · Cited by 21

Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophilia

Kumar, R., Bouskill, V., Schneiderman, J. E., Pluthero, F. G., Kahr, W. H. A., Craik, A., Clark, D. S., Whitney, K., Zhang, C., Rand, M. L., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-09-0757 · Cited by 20

The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock

Saad, A. F., & Maybauer, M. O. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.03.008 · Cited by 20

G protein‐coupled receptor kinase 2 moderates recruitment of THP‐1 cells to the endothelium by limiting histamine‐invoked Weibel‐Palade body exocytosis

Stevenson, N. L., Martı́n-Martı́n, B., Freeman, J., Kriston-Vizi, J., Ketteler, R., & Cutler, D. F. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12470 · Cited by 19

The Cell Biology of Vasopressin Action

Brown, D., & Fenton, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10011-9 · Cited by 20

Acquired hemophilia: a rare but life-threatening potential cause of bleeding in the intensive care unit

Shander, A., Walsh, C., & Cromwell, C. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2258-5 · Cited by 19

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

Windyga, J., Dolan, G., Altisent, C., Κατσαρού, Ό., Fernández, M. F. L., Zülfikar, B., & EHTSB, T. (2016) · Haemophilia · doi:10.1111/hae.12955 · Cited by 19

Endothelial dysfunction markers and immune response indices in cosmonauts’ blood after long-duration space flights

Kuzichkin, D. S., Ничипорук, И. А., Zhuravleva, O. A., Маркин, А. А., Петровна, Р. М., Zhuravleva, T. V., Sadova, A. A., Валерьевна, К. О., Шмаров, В. А., & Ponomarev, S. A. (2022) · npj Microgravity · doi:10.1038/s41526-022-00237-0 · Cited by 18

Bleeding in the patient with a malignancy

Escobar, M. A. (2011) · Cancer · doi:10.1002/cncr.26304 · Cited by 18

Plasma microRNAs levels are different between pulmonary and extrapulmonary ARDS patients: a clinical observational study

Zheng, Y., Liu, S., Sun, Q., Xie, J., Xu, J., Li, Q., Pan, C. S., Liu, L., & Huang, Y. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0370-1 · Cited by 18

Addition of vasopressin synthetic analogue [V4Q5]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models

Garona, J., Pífano, M., Pastrián, M. B., Gomez, D. E., Ripoll, G. V., & Alonso, D. F. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9799-5 · Cited by 17

Vaptans or voluntary increased hydration to protect the kidney: how do they compare?

Bankir, L., Guerrot, D., & Bichet, D. G. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab278 · Cited by 16

Vasopressin receptor antagonists: potential indications and clinical results

ARAI, Y., Fujimori, A., Sudoh, K., & Sasamata, M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.009 · Cited by 16

Treatment of patients with von Willebrand disease

Alikhan, R. (2011) · Journal of Blood Medicine · doi:10.2147/jbm.s9890 · Cited by 16

Treatment options for hyponatremia in heart failure

Goldsmith, S. R. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9110-1 · Cited by 16

Current controversies in the diagnosis and management of von Willebrand disease

Neff, A. T. (2015) · Therapeutic Advances in Hematology · doi:10.1177/2040620715587879 · Cited by 15

Endothelial Cell von Willebrand Factor Secretion in Health and Cardiovascular Disease

Rusu, L., & Minshall, R. D. (2018) · InTech eBooks · doi:10.5772/intechopen.74029 · Cited by 15

Functional variation in the arginine vasopressin 2 receptor as a modifier of human plasma von Willebrand factor levels

Nossent, A. Y., Robben, J. H., Deen, P. M. T., Vos, H. L., Rosendaal, F. R., Doggen, C. J. M., HANSEN, J. L., Sheikh, S. P., Bertina, R. M., & Eikenboom, J. C. J. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03884.x · Cited by 14

Vasopressor effects on venous return in septic patients: a review

Feldheiser, A., Gelman, S., Chew, M. S., & Stopfkuchen-Evans, M. F. (2021) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001508 · Cited by 13

Desmopressinin vitroeffects on platelet function, monitored with Multiplate, ROTEM and Sonoclot

Pearson, K., Jensen, H., Kander, T., & Schött, U. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2016.1149615 · Cited by 13

N EW A SPECTS IN THE P ATHOGENESIS AND T REATMENT OF T HROMBOTIC T HROMBOCYTOPENIC P URPURA AND H EMOLYTIC U REMIC S YNDROME

Raife, T. J., & Montgomery, R. R. (2001) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2001.00044.x · Cited by 12

Transient Mild Hyperthermia Induces E-selectin Mediated Localization of Mesoporous Silicon Vectors in Solid Tumors

Kirui, D. K., Mai, J., Palange, A. L., Qin, G., van de Ven, A. L., Liu, X., Shen, H., & Mauro Ferrari, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086489 · Cited by 12

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2‑expressing human osteosarcoma

Sobol, N. T., Solernó, L. M., Beltrán, B., Vásquez, L., Ripoll, G. V., Garona, J., & Alonso, D. F. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9998 · Cited by 12

Regulatory Components of the Alternative Complement Pathway in Endothelial Cell Cytoplasm, Factor H and Factor I, Are Not Packaged in Weibel-Palade Bodies

Turner, N. A., Sartain, S. E., Shiu-Ki, H., & Moake, J. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121994 · Cited by 12

Chronic hypertension increases aortic endothelial hydraulic conductivity by upregulating endothelial aquaporin-1 expression

Toussaint, J. D., Raval, C., Nguyen, T., Fadaifard, H., Joshi, S., Wolberg, G., Quarfordt, S. H., Jan, K.-M., & Rumschitzki, D. S. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2016 · Cited by 12

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis

Li, X., Li, W., Li, Y., Dong, C., & Zhu, P. (2023) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2023.04.002 · Cited by 12

Arginine vasopressin receptor 2 activation promotes microvascular permeability in sepsis

Lopez, E., Fukuda, S., Módis, K., Fujiwara, O., Enkhtaivan, B., Trujillo-Abarca, R., Ihara, K., Lima-López, F., Pérez‐Bello, D., Szabó, C., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105272 · Cited by 11

A snake toxin as a theranostic agent for the type 2 vasopressin receptor

Droctové, L., Lancien, M., Tran, V. L., Susset, M., Jégo, B., Théodoro, F., Kessler, P., Mourier, G., Robin, P., Diarra, S. S., et al. (2020) · Theranostics · doi:10.7150/thno.47485 · Cited by 16

Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells

Hough, C. A., Notley, C. R. P., Mo, A., Videl, B., & Lillicrap, D. (2022) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15841 · Cited by 12

Effect of Levothyroxine Administration on Hemostatic Analytes in Doberman Pinschers with von Willebrand Disease

Heseltine, J. C., Panciera, D. L., Troy, G. C., Monroe, W. E., Brooks, M. B., & Feldman, B. F. (2005) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2005.tb02721.x · Cited by 11

A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD

Kloosterman, R., Zago‐Schmitt, M., Grabell, J., Thibeault, L., Lima, P., Bowman, M. L., Tyryshkin, K., Hindmarch, C. C. T., Renwick, N. M., & James, P. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007884 · Cited by 10

Increased von Willebrand factor parameters in children with febrile seizures

Pechmann, A., Wellmann, S. M., Stoecklin, B., Krüger, M., & Zieger, B. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210004 · Cited by 10

Structure and multiple functions of von Willebrand factor

Haberichter, S. L., & O’Donnell, J. S. (2025) · Haematologica · doi:10.3324/haematol.2024.286029 · Cited by 9

A prospective randomized trial of desmopressin in canine mammary carcinoma

Sørenmo, K. U., Durham, A. C., Evans, B. J., Scavello, H., & Stefanovski, D. (2020) · Veterinary and Comparative Oncology · doi:10.1111/vco.12619 · Cited by 9

Polygenic risk scores and risk stratification in deep vein thrombosis.

Faro, V. L., Johansson, T., Hoglund, J., Hadizadeh, F., & Johansson, Å. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.06.011 · Cited by 5

Laboratory Testing for von Willebrand Disease: Toward a Mechanism-Based Classification

Torres, R., & Fedoriw, Y. D. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.06.005 · Cited by 9

Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent

Garona, J., Pífano, M., Ripoll, G. V., & Alonso, D. F. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2019.08.010 · Cited by 9

Desmopressin nasal spray reduces blood loss and improves the quality of the surgical field during functional endoscopic sinus surgery

Safaeian, R., Hassani, V., Ghandi, A., & Mohseni, M. (2021) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_227_19 · Cited by 9

Hyponatremia: an update on current pharmacotherapy

Shchekochikhin, D., Tkachenko, O., & Schrier, R. W. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.781584 · Cited by 8

Von Willebrand Factor in Health and Disease

Авдонин, П. П., Tsvetaeva, N. V., Goncharov, N. V., Rybakova, E. Y., Trufanov, S. K., Tsitrina, A. A., & Avdonin, P. V. (2021) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747821040036 · Cited by 8

Intracellular receptor EPAC regulates von Willebrand factor secretion from endothelial cells in a PI3K-/eNOS-dependent manner during inflammation

Xiao, J., Zhang, B., Su, Z., Liu, Y., Shelite, T. R., Chang, Q., Qiu, Y., Bei, J., Wang, P., Bukreyev, A. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101315 · Cited by 8

Acute pulmonary thromboembolism occurring during treatment with tolvaptan in a patient with autosomal-dominant polycystic kidney disease

Morimoto, K., Akai, Y., Matsui, M., Yano, H., Tagawa, M., Samejima, K., & Saito, Y. (2017) · CEN Case Reports · doi:10.1007/s13730-016-0245-y · Cited by 8

Response to DDAVP in children with von Willebrand disease type 2

Budde, U., Beutel, K., Hassenpflug, W.-A., Hauch, H., Obser, T., Oyen, F., Schneppenheim, S., Schrum, J., & Schneppenheim, R. (2009) · Hämostaseologie · doi:10.1055/s-0037-1617014 · Cited by 8

Case Report: Hyponatremia Secondary to Desmopressin Administration Prior to Percutaneous Kidney Biopsy: A Case-Based Review

Vornicu, A., Obrișcă, B., Cotruţă, B., Dulămea, A. O., Caceaune, N., & Ismail, G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.696904 · Cited by 7

Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In Vivo

Buchtele, N., Kovacevic, K. D., Brostjan, C., Schwameis, M., Hayden, H., Derhaschnig, U., Firbas, C., Jilma, B., & Schoergenhofer, C. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1712448 · Cited by 7

Integrative phosphoproteomic analyses reveal hemostatic-endothelial signaling interplay

Groten, S. A., van den Eshof, B. L., van Alphen, F. P. J., Meijer, A. B., van den Biggelaar, M., & Hoogendijk, A. J. (2024) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2024.10.011 · Cited by 6

The Use of Fluorescently Labeled ARC1779 Aptamer for Assessing the Effect of H2O2 on von Willebrand Factor Exocytosis

Авдонин, П. П., Trufanov, S. K., Rybakova, E. Y., Tsitrina, A. A., Goncharov, N. V., & Avdonin, P. V. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297921020012 · Cited by 6

Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease

Takahara, M., Soga, Y., Fujihara, M., Iida, O., & Kawasaki, D. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01992-4 · Cited by 6

FVIII/VWF ratio is not a reliable predictor of VWD in children

Branchford, B. R., Ruegg, K. A., Villalobos‐Menuey, E., Jacobson, L. J., Paola, J. A. D., & Manco‐Johnson, M. J. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24860 · Cited by 6

Tolvaptan inhibition of desmopressin effects on coagulation factors in a patient with decreased von Willebrand factor and polycystic kidney disease

Blumenfeld, J. D., Tepler, J., Mauer, A. C., Coller, B. S., Bichet, D. G., & Smith, B. (2011) · Blood · doi:10.1182/blood-2011-04-347328 · Cited by 6

Recurrent myocardial infarctions in a young football player secondary to thrombophilia, associated with elevated factor VIII activity

Vacek, T. P., Yu, S., Rahman, S., Grubb, B. P., KOSINSKI, D. J., Verghese, C., Eltahawy, E. A., & Shafiq, Q. (2014) · International Medical Case Reports Journal · doi:10.2147/imcrj.s68416 · Cited by 6

Desmopressin (DDAVP)

Cattaneo, M., & Mannucci, P. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00062-x · Cited by 6

The Molecular Basis of Von Willebrand Disease

Baronciani, L., & Mannucci, P. M. (2010) · doi:10.1002/9781444318531.ch19 · Cited by 6

F8 gene variants influence the response to desmopressin in hemophilia A carriers

Guillet, B., d’Oiron, R., Trossaërt, M., Wibaut, B., Pan‐Petesch, B., Frotscher, B., Volot, F. G., Ardillon, L., Desage, S., Falaise, C., et al. (2025) · Blood · doi:10.1182/blood.2025029829 · Cited by 5

Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases

Gilles, N. (2023) · Biology · doi:10.3390/biology12040544 · Cited by 5

Aquaporin 2 gene variations, risk of venous thrombosis and plasma levels of von Willebrand factor and factor VIII

Nossent, A. Y., Vos, H. L., Rosendaal, F. R., Bertina, R. M., & Eikenboom, J. C. J. (2008) · Haematologica · doi:10.3324/haematol.12296 · Cited by 5

[Alternative nutrition and glutathione levels].

Krajcovicová-Kudlácková, M., Šimončič, R., Béderová, A., Brtková, A., Magálová, T., & Barteková, S. (1999) · PubMed · Cited by 5

Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant manner

Loomans, J. I., Stokhuijzen, E., Peters, M., & Fijnvandraat, K. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s2.003 · Cited by 5

Vasopressin Analog [V4Q5]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models

Sobol, N. T., Solernó, L. M., Llavona, C., Alonso, D. F., & Garona, J. (2023) · World Journal of Oncology · doi:10.14740/wjon1715 · Cited by 4

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score

Guillet, B., Pawlowski, M., Boisseau, P., Repessé, Y., Beurrier, P., Bayart, S., Delavenne, X., Trossaërt, M., & Lenting, P. J. (2024) · Thrombosis and Haemostasis · doi:10.1055/a-2329-3375 · Cited by 4

Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus

Nossent, A. Y., Ellenbroek, J. H., Frölich, M., Bertina, R. M., Knoers, N. V. A. M., & Eikenboom, J. C. J. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.03.014 · Cited by 4

Arginine vasopressin attenuates the effects of TNF-α in aortic endothelial cells by inducing ectodomain shedding of TNF receptor 1

Yang, W. S., Moon, S. Y., Han, N. J., Lee, M. J., & Park, S.-K. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.02.125 · Cited by 4

The safety and efficacy of tolvaptan in the treatment of patients with autosomal dominant polycystic kidney disease: A systematic review and meta-analysis

Li, X., Li, W., Li, Y., Dong, C., & Zhu, P. (2022) · Nefrología · doi:10.1016/j.nefro.2022.10.002 · Cited by 4

Treatment Options for Hyponatremia in Heart Failure

Goldsmith, S. R. (2010) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2010.00164.x · Cited by 4

Nephrogenic Diabetes Insipidus

Deen, P. M. T., van Os, C. H., & Knoers, N. V. A. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00022-x · Cited by 4

Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial

Kumar, R., Dunn, A. L., Schneiderman, J. E., Gonzales, A., Bouskill, V., Widener, P., Stanek, J. R., Pluthero, F. G., Waller, A. P., Tarango, C., et al. (2022) · Blood · doi:10.1182/blood.2022016146 · Cited by 4

Agents which Increase Synthesis and Release of Tissue-Type Plasminogen Activator

Kooistra, T., & EMEIS, J. J. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56637-0_20 · Cited by 4

EPAC regulates von Willebrand factor secretion from endothelial cells in a PI3K/eNOS-dependent manner during inflammationPreprint

Xiao, J., Zhang, B., Su, Z., Liu, Y., Shelite, T. R., Chang, Q., Wang, P., Bukreyev, A. A., Soong, L., Jin, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.04.282806 · Cited by 4

Rewriting the script: gene therapy and genome editing for von Willebrand Disease

Barraclough, A., Bär, I., van Duijl, T. T., Fijnvandraat, K., Eikenboom, J. C. J., Leebeek, F. W. G., Bierings, R., Voorberg, J., & Trasanidou, D. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1620438 · Cited by 3

von Willebrand factor propeptide to antigen ratio identifies platelet activation and reduced von Willebrand factor survival phenotype in mice

Jacobi, P. M., Kanaji, S., Jakab, D., Gehrand, A. L., Johnsen, J. M., & Haberichter, S. L. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13934 · Cited by 3

Understanding the Clotting Cascade, Regulators, and Clinical Modulators of Coagulation

Pilli, V. S. S. (2018) · InTech eBooks · doi:10.5772/intechopen.75141 · Cited by 3

Diabetes Insipidus

Christensen, J., & Rittig, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00005-1 · Cited by 3

A woman with postoperative hyponatremia related to desmopressin acetate

Schreiber, A., Kubitza, S., & Luft, F. C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.04.017 · Cited by 3

Study of the mechanism of hemostatic effect of desmopressin

Зубаиров, Д. М., Андрушко, И. А., Zubairova, L. D., & Svintenok, G. Y. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0288-3 · Cited by 3

Treating hyponatremia in heart failure

Goldsmith, S. R. (2006) · Current Cardiology Reports · doi:10.1007/s11886-006-0035-9 · Cited by 3

Symposium in memory of Professor Inga Marie Nilsson

Astermark, J., Aledort, L. M., Berntorp, E., Blombäck, M., Dahlbäck, B., Freiburghaus, C., Giannelli, F., Ginsburg, D., Holmberg, L., Hoyer, L., et al. (2001) · Haemophilia · doi:10.1046/j.1365-2516.2001.00524.x · Cited by 3

The Physiology and Clinical Applications of Vasopressin in Critical Illness

Russell, J. C., & Glover, P. (2002) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01207-3 · Cited by 3

Vasopressin: a possible link between hypoxia and hypertension

Szczepanska‐Sadowska, E. K., & Żera, T. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00103 · Cited by 2

Therapeutic potential of vasopressin in the treatment of neurological disorders

Mishra, S., Grewal, J., Wal, P., Bhivshet, G. U., Tripathi, A. K., & Walia, V. (2024) · Peptides · doi:10.1016/j.peptides.2024.171166 · Cited by 2

Development and Validation of a Liquid Chromatography High‐Resolution Mass Spectrometry Method for Blood Desmopressin Quantification and Its Application in Hemophilia A Patients

Hodin, S., Escal, J., Féliu, C., Pontis, A., Josset, L., Serban, A., Guillet, B., & Delavenne, X. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10086 · Cited by 2

Desmopressin (DDAVP)

Mannucci, P. M., & Cattaneo, M. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50829-6 · Cited by 2

Système du plasminogène et son exploration

Lebrazi, J., Samama, M., & Bachmann, F. (2003) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(03)00048-7 · Cited by 2

Article Reference

(2016)

DDAVP-induced release of Von Willebrand factor from endothelial cells in vitro: The effect of plasma and blood cells

Hashemi, S., Tackaberry, E., Palmer, D. S., Rock, G., & Ganz, P. R. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90058-l · Cited by 40

Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

Kaufmann, J. E., & Vischer, U. M. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00190.x · Cited by 255

The effect of DDAVP on plasma levels of von Willebrand antigen II in normal individuals and patients with von Willebrand's disease

McCarroll, D., Ruggeri, Z., & Montgomery, R. (1984) · Blood · doi:10.1182/blood.v63.3.532.532 · Cited by 26

Epinephrine Induces von Willebrand Factor Release from Cultured Endothelial Cells: Involvement of Cyclic AMP-dependent Signalling in Exocytosis

Vischer, U. M., & Wollheinn, C. B. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656135 · Cited by 110